Thursday - March 28, 2024
University of Texas: Testosterone Nasal Spray to Treat Anxiety Disorders
December 19, 2020
AUSTIN, Texas, Dec. 19 (TNSRes) -- The University of Texas issued the following news release:

A testosterone-containing nasal spray received its second U.S. patent and its first patent in Europe, making it the first testosterone therapy licensed to treat anxiety disorders.

Although testosterone therapy is most often marketed and prescribed to men suffering from "low T" -- testosterone deficiency or hypogonadism -- researchers with The University of Texas at Au . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products